The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol cover the XVIII International AIDS Conference (AIDS 2010)
Medical News

HIV Drugs Should Be Initiated Earlier, Says UN

July 19, 2010

All HIV-positive people with a CD4+ T-cell count of 350 cells/mm3 or lower should begin antiretroviral therapy (ART), the World Health Organization said on Monday. WHO released the first revision to its ART recommendations in four years at the 18th International AIDS Conference in Vienna. WHO's revised ART guidelines reiterate advice from 2009 that treatment should begin earlier.

"All adolescents and adults including pregnant women with HIV infection and CD4 counts of 350 cells/mm3, should start ART, regardless of the presence or absence of clinical symptoms," WHO advised. "Those with severe or advanced clinical disease (WHO clinical stage three or four) should start ART irrespective of their CD4 cell count."


WHO recommendations favor simplified first- and second-line ART regimens of low toxicity and in fixed doses. Initial ART should contain a non-nucleoside reverse transcriptase inhibitor, either nevirapine or efavirenz, plus two nucleoside reverse transcriptase inhibitors, one of which should be lamivudine or emtricitabine and the other zidovudine or tenofovir, the report said.

"Countries should take steps to progressively reduce the use of stavudine (d4T) in first-line regimens because of its well-recognized toxicities," WHO said.

Patients who initiate treatment at a CD4 count of 350 or less will be exposed to an additional one or two years of ART, its side effects and risk of viral resistance, WHO acknowledged. The new recommendations, therefore, "may require more laboratory monitoring than current regimens," the agency said.

To view WHO's newly revised antiretroviral recommendations, visit:

Back to other news for July 2010

Adapted from:
Agence France Presse


This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
HIV Medications: When to Start and What to Take -- A Guide From
More on When to Begin HIV Treatment

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

AIDS 2010
Choose a Topic:
Previous Conferences